Open AccessColon cleansing efficacy and safety with 1 L NER1006 versus 2 L polyethylene glycol + ascorbate: a randomized phase 3 trial
Author(s) -
Raf Bisschops,
Jonathan Manning,
Lucy Clayton,
Richard Ng Kwet Shing,
Marco Antonio Álvarez,
on behalf of the MORA Study Group
Publication year - 2018
Publication title -
endoscopy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.78
H-Index - 143
eISSN - 1438-8812
pISSN - 0013-726X
DOI - 10.1055/a-0638-8125
Subject(s) - medicine , morning , randomized controlled trial , colonoscopy , evening , randomization , polyethylene glycol , peg ratio , regimen , gastroenterology , surgery , colorectal cancer , cancer , chemistry , biochemistry , astronomy , economics , physics , finance
Polyethylene glycol (PEG)-based bowel preparations are effective cleansers but many require high-volume intake. This phase 3, randomized, blinded, multicenter, parallel-group, central reader-assessed study assessed the 1 L PEG NER1006 bowel preparation vs. standard 2 L PEG with ascorbate (2LPEG).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom